Current pharmacy funding model preventing Rowlands from realising ‘positive bottom-line’

Rowlands has reported losses of £11.6 million in the year ending January 31, 2021, blaming “current funding” for its inability to “realise a positive bottom-line result”, a spokesperson has told C+D.